Dhampur Bio Organics Approves FY 2026 Results, Recommends Dividend, and Announces Key Corporate Changes

Dhampur Bio Organics Approves FY 2026 Results, Recommends Dividend, and Announces Key Corporate Changes​

Dhampur Bio Organics Limited held its Board of Directors meeting on May 30, 2026, approving audited financial results, recommending a dividend payment, and finalizing several key corporate and governance decisions.

The Board approved the audited standalone and consolidated financial results for the quarter and the year ended March 31, 2026. The directors also recommended the payment of a final dividend of Rs. 1.50 per equity share (face value of Rs. 10) for the financial year ended March 31, 2026, subject to shareholder approval. The record date for this dividend is set for July 17, 2026.

Financial Performance and Segment Highlights​

The company presented comprehensive financial statements for the period. The consolidated results, which incorporate the subsidiaries Dhampur International Pte Limited and Sonitron Bio Organics Private Limited, show the following operational data:

Consolidated Segment Revenue (₹ in Crore)


The Board also approved the recommendation of a commission for the Financial Year 2025-26 to Non-Executive Directors.

Leadership and Corporate Governance Updates​

Several major structural and leadership changes were recommended to the shareholders:

• Leadership Restructuring: Mr. Gautam Goel was re-designated as the Chairman and Chief Executive Officer (CEO), effective May 31, 2026.
• Articles of Association: The Board approved the amendment of the Company's Articles of Association (AOA) by inserting a new Article 125A. This amendment enables the Chief Executive Officer and/or Managing Director to be appointed as the Chairman of the Company, pending shareholder approval.
• Remuneration Revisions: The Board also reviewed and approved revisions in the remuneration of Ms. Maayashree Goel and Ms. Meerashree Goel.
• Acquisition: The Company’s board recommended the acquisition of Sonitron Chemicals Private Limited. The target entity, which focuses on manufacturing and distribution of FMCG products, was approved for acquisition via a cash consideration. The acquisition was set to be completed within 60 days of the Board's approval.
• Audit and Advisory: The Board approved the re-appointment of M/s Mittal Gupta & Company, Chartered Accountants, as the Statutory Auditors of the Company for a second term of five years, commencing from the Financial Year 2026-27. Additionally, Mr. S. R. Kapur, Cost Accountant, was re-appointed as the Cost Auditor for the Financial Year 2026-27.

Financial Summary Table​

The following table summarizes the Key Financial Highlights (₹ in Crore):


***

The Company is scheduled to hold its 6th Annual General Meeting of the Shareholders on Friday, July 24, 2026.

The audited standalone and consolidated financial results were presented to the market by the Company. The audited results were reviewed by the Audit Committee and approved by the Board of Directors.

DBOL Stock Price Movement​

On Friday, Dhampur Bio Organics Limited shares gained 1.73%, settling at ₹107.95 after posting a significant increase of ₹1.82 per share. The stock saw robust activity during the session, trading on a volume of 89,145 shares.